The Committee on Dosimetry for the Radiation Effects Research Foundation (RERF) was set up more than a decade ago at the request of the U.S. Department of Energy. It was charged with monitoring work and experimental results related to the Dosimetry System 1986 (DS86) used by RERF to reconstruct the radiation doses to the survivors in Hiroshima and Nagasaki. At the time it was established, DS86 was believed to be the best available dosimetric system for RERF, but questions have persisted about some features, especially the estimates of neutrons resulting from the Hiroshima bomb. This book describes the current situation, the gamma-ray dosimetry, and such dosimetry issues as thermal-neutron discrepancies between measurement and calculation at various distances in Hiroshima and Nagasaki. It recommends approaches to bring those issues to closure and sets the stage for the recently convened U.S. and Japan Working Groups that will develop a new dosimetry for RERF. The book outlines the changes relating to DS86 in the past 15 years, such as improved numbers that go into, and are part of, more sophisticated calculations for determining the radiations from bombs that reach certain distances in air, and encourages incorporation of the changes into a revised dosimetry system.
The Committee on Dosimetry for the Radiation Effects Research Foundation (RERF) was set up more than a decade ago at the request of the U.S. Department of Energy. It was charged with monitoring work and experimental results related to the Dosimetry System 1986 (DS86) used by RERF to reconstruct the radiation doses to the survivors in Hiroshima and Nagasaki. At the time it was established, DS86 was believed to be the best available dosimetric system for RERF, but questions have persisted about some features, especially the estimates of neutrons resulting from the Hiroshima bomb. This book describes the current situation, the gamma-ray dosimetry, and such dosimetry issues as thermal-neutron discrepancies between measurement and calculation at various distances in Hiroshima and Nagasaki. It recommends approaches to bring those issues to closure and sets the stage for the recently convened U.S. and Japan Working Groups that will develop a new dosimetry for RERF. The book outlines the changes relating to DS86 in the past 15 years, such as improved numbers that go into, and are part of, more sophisticated calculations for determining the radiations from bombs that reach certain distances in air, and encourages incorporation of the changes into a revised dosimetry system.
The Radiation Exposure Compensation Act (RECA) was set up by Congress in 1990 to compensate people who have been diagnosed with specified cancers and chronic diseases that could have resulted from exposure to nuclear-weapons tests at various U.S. test sites. Eligible claimants include civilian onsite participants, downwinders who lived in areas currently designated by RECA, and uranium workers and ore transporters who meet specified residence or exposure criteria. The Health Resources and Services Administration (HRSA), which oversees the screening, education, and referral services program for RECA populations, asked the National Academies to review its program and assess whether new scientific information could be used to improve its program and determine if additional populations or geographic areas should be covered under RECA. The report recommends Congress should establish a new science-based process using a method called "probability of causation/assigned share" (PC/AS) to determine eligibility for compensation. Because fallout may have been higher for people outside RECA-designated areas, the new PC/AS process should apply to all residents of the continental US, Alaska, Hawaii, and overseas US territories who have been diagnosed with specific RECA-compensable diseases and who may have been exposed, even in utero, to radiation from U.S. nuclear-weapons testing fallout. However, because the risks of radiation-induced disease are generally low at the exposure levels of concern in RECA populations, in most cases it is unlikely that exposure to radioactive fallout was a substantial contributing cause of cancer.
Growing public concern about releases of radiation into the environment has focused attention on the measurement of exposure of people living near nuclear weapons production facilities or in areas affected by accidental releases of radiation. Radiation-Dose Reconstruction for Epidemiologic Uses responds to the need for criteria for dose reconstruction studies, particularly if the doses are to be useful in epidemiology. This book provides specific and practical recommendations for whether, when, and how studies should be conducted, with an emphasis on public participation. Based on the expertise of scientists involved in dozens of dose reconstruction projects, this volume Provides an overview of the basic requirements and technical aspects of dose reconstruction. Presents lessons to be learned from dose reconstructions after Chernobyl, Three Mile Island, and elsewhere. Explores the potential benefits and limitations of biological markers. Discusses how to establish the "source term"--that is, to determine what was released. Explores methods for identifying the environmental pathways by which radiation reaches the body. Offers details on three major categories of dose assessment.
From 1945 through 1962, the US atmospheric nuclear weapons testing program involved hundreds of thousands of military and civilian personnel, and some of them were exposed to ionizing radiation. Veterans' groups have since been concerned that their members' health was affected by radiation exposure associated with participation in nuclear tests and have pressured Congress for disability compensation. Several pieces of legislation have been passed to compensate both military and civilian personnel for such health effects. Veterans' concerns about the accuracy of reconstructed doses prompted Congress to have the General Accounting Office (GAO) review the dose reconstruction program used to estimate exposure. The GAO study concluded that dose reconstruction is a valid method of estimating radiation dose and could be used as the basis of compensation. It also recommended an independent review of the dose reconstruction program. The result of that recommendation was a congressional mandate that the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense, ask the National Research Council to conduct an independent review of the dose reconstruction program. In response to that request, the National Research Council established the Committee to Review the Dose Reconstruction Program of the Defense Threat Reduction Agency in the Board on Radiation Effects Research (BRER). The committee randomly selected sample records of doses that had been reconstructed by DTRA and carefully evaluated them. The committee's report describes its findings and provides responses to many of the questions that have been raised by the veterans.
In 1996, NATO issued guidance for the exposure of military personnel to radiation doses different from occupational dose levels, but not high enough to cause acute health effects-and in doing so set policy in a new arena. Scientific and technological developments now permit small groups or individuals to use, or threaten to use, destructive devices (nuclear, biological, chemical, and cyber-based weaponry, among others) targeted anywhere in the world. Political developments, such as the loss of political balance once afforded by competing superpowers, have increased the focus on regional and subregional disputes. What doctrine should guide decisionmaking regarding the potential exposure of troops to radiation in this changed theater of military operations? In 1995, the Office of the U.S. Army Surgeon General asked the Medical Follow-up Agency of the Institute of Medicine to provide advice. This report is the final product of the Committee on Battlefield Radiation Exposure Criteria convened for that purpose. In its 1997 interim report, Evaluation of Radiation Exposure Guidance for Military Operations, the committee addressed the technical aspects of the NATO directive. In this final report, the committee reiterates that discussion and places it in an ethical context.
BEIR VII develops the most up-to-date and comprehensive risk estimates for cancer and other health effects from exposure to low-level ionizing radiation. It is among the first reports of its kind to include detailed estimates for cancer incidence in addition to cancer mortality. In general, BEIR VII supports previously reported risk estimates for cancer and leukemia, but the availability of new and more extensive data have strengthened confidence in these estimates. A comprehensive review of available biological and biophysical data supports a "linear-no-threshold" (LNT) risk modelâ€"that the risk of cancer proceeds in a linear fashion at lower doses without a threshold and that the smallest dose has the potential to cause a small increase in risk to humans. The report is from the Board on Radiation Research Effects that is now part of the newly formed Nuclear and Radiation Studies Board.
A Review of the CDC-NCI Draft Report on a Feasibility Study of the Health Consequences to the American Population from Nuclear Weapons Tests Conducted by the United States and Other Nations
A Review of the CDC-NCI Draft Report on a Feasibility Study of the Health Consequences to the American Population from Nuclear Weapons Tests Conducted by the United States and Other Nations
This report is a review of the draft feasibility study that was issued at the request of Congress by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI). Over 500 atmospheric nuclear-weapons tests were conducted at various sites around the world during 1945-1980. As public awareness and concern mounted over the possible health hazards associated with exposure to the fallout from weapons testing, a feasibility study was initiated by CDC and NCI to assess the extent of the hazard. The CDC-NCI study claims that the fallout might have led to approximately 11,000 excess deaths, most caused by thyroid cancer linked to exposure to iodine-131. The committee noted that CDC and NCI used the best available data to estimate exposure and health hazards. The committee does not recommend an expanded study of exposure to radionuclides other than 131I since radiation doses from those radionuclides were much lower than those from 131I. It also recommended that CDC urge Congress to prohibit the destruction of all remaining records relevant to fallout.
The Committee on Dosimetry for the Radiation Effects Research Foundation (RERF) was set up more than a decade ago at the request of the U.S. Department of Energy. It was charged with monitoring work and experimental results related to the Dosimetry System 1986 (DS86) used by RERF to reconstruct the radiation doses to the survivors in Hiroshima and Nagasaki. At the time it was established, DS86 was believed to be the best available dosimetric system for RERF, but questions have persisted about some features, especially the estimates of neutrons resulting from the Hiroshima bomb. This book describes the current situation, the gamma-ray dosimetry, and such dosimetry issues as thermal-neutron discrepancies between measurement and calculation at various distances in Hiroshima and Nagasaki. It recommends approaches to bring those issues to closure and sets the stage for the recently convened U.S. and Japan Working Groups that will develop a new dosimetry for RERF. The book outlines the changes relating to DS86 in the past 15 years, such as improved numbers that go into, and are part of, more sophisticated calculations for determining the radiations from bombs that reach certain distances in air, and encourages incorporation of the changes into a revised dosimetry system.
This book reevaluates the health risks of ionizing radiation in light of data that have become available since the 1980 report on this subject was published. The data include new, much more reliable dose estimates for the A-bomb survivors, the results of an additional 14 years of follow-up of the survivors for cancer mortality, recent results of follow-up studies of persons irradiated for medical purposes, and results of relevant experiments with laboratory animals and cultured cells. It analyzes the data in terms of risk estimates for specific organs in relation to dose and time after exposure, and compares radiation effects between Japanese and Western populations.
From 1945 through 1962, the US atmospheric nuclear weapons testing program involved hundreds of thousands of military and civilian personnel, and some of them were exposed to ionizing radiation. Veterans' groups have since been concerned that their members' health was affected by radiation exposure associated with participation in nuclear tests and have pressured Congress for disability compensation. Several pieces of legislation have been passed to compensate both military and civilian personnel for such health effects. Veterans' concerns about the accuracy of reconstructed doses prompted Congress to have the General Accounting Office (GAO) review the dose reconstruction program used to estimate exposure. The GAO study concluded that dose reconstruction is a valid method of estimating radiation dose and could be used as the basis of compensation. It also recommended an independent review of the dose reconstruction program. The result of that recommendation was a congressional mandate that the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense, ask the National Research Council to conduct an independent review of the dose reconstruction program. In response to that request, the National Research Council established the Committee to Review the Dose Reconstruction Program of the Defense Threat Reduction Agency in the Board on Radiation Effects Research (BRER). The committee randomly selected sample records of doses that had been reconstructed by DTRA and carefully evaluated them. The committee's report describes its findings and provides responses to many of the questions that have been raised by the veterans.
The Radiation Exposure Compensation Act (RECA) was set up by Congress in 1990 to compensate people who have been diagnosed with specified cancers and chronic diseases that could have resulted from exposure to nuclear-weapons tests at various U.S. test sites. Eligible claimants include civilian onsite participants, downwinders who lived in areas currently designated by RECA, and uranium workers and ore transporters who meet specified residence or exposure criteria. The Health Resources and Services Administration (HRSA), which oversees the screening, education, and referral services program for RECA populations, asked the National Academies to review its program and assess whether new scientific information could be used to improve its program and determine if additional populations or geographic areas should be covered under RECA. The report recommends Congress should establish a new science-based process using a method called "probability of causation/assigned share" (PC/AS) to determine eligibility for compensation. Because fallout may have been higher for people outside RECA-designated areas, the new PC/AS process should apply to all residents of the continental US, Alaska, Hawaii, and overseas US territories who have been diagnosed with specific RECA-compensable diseases and who may have been exposed, even in utero, to radiation from U.S. nuclear-weapons testing fallout. However, because the risks of radiation-induced disease are generally low at the exposure levels of concern in RECA populations, in most cases it is unlikely that exposure to radioactive fallout was a substantial contributing cause of cancer.
As part of the Vision for Space Exploration (VSE), NASA is planning for humans to revisit the Moon and someday go to Mars. An important consideration in this effort is protection against the exposure to space radiation. That radiation might result in severe long-term health consequences for astronauts on such missions if they are not adequately shielded. To help with these concerns, NASA asked the NRC to further the understanding of the risks of space radiation, to evaluate radiation shielding requirements, and recommend a strategic plan for developing appropriate mitigation capabilities. This book presents an assessment of current knowledge of the radiation environment; an examination of the effects of radiation on biological systems and mission equipment; an analysis of current plans for radiation protection; and a strategy for mitigating the risks to VSE astronauts.
A Review of the CDC-NCI Draft Report on a Feasibility Study of the Health Consequences to the American Population from Nuclear Weapons Tests Conducted by the United States and Other Nations
A Review of the CDC-NCI Draft Report on a Feasibility Study of the Health Consequences to the American Population from Nuclear Weapons Tests Conducted by the United States and Other Nations
This report is a review of the draft feasibility study that was issued at the request of Congress by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI). Over 500 atmospheric nuclear-weapons tests were conducted at various sites around the world during 1945-1980. As public awareness and concern mounted over the possible health hazards associated with exposure to the fallout from weapons testing, a feasibility study was initiated by CDC and NCI to assess the extent of the hazard. The CDC-NCI study claims that the fallout might have led to approximately 11,000 excess deaths, most caused by thyroid cancer linked to exposure to iodine-131. The committee noted that CDC and NCI used the best available data to estimate exposure and health hazards. The committee does not recommend an expanded study of exposure to radionuclides other than 131I since radiation doses from those radionuclides were much lower than those from 131I. It also recommended that CDC urge Congress to prohibit the destruction of all remaining records relevant to fallout.
Analysis of Cancer Risks in Populations near Nuclear Facilities is a pilot study requested by the United States Nuclear Regulatory Commission (USNRC) to assess the risk of cancer near nuclear facilities in the United States. This effort is being carried out in two phases. The Phase 1 study recommended two study designs appropriate for assessing cancer risks near nuclear facilities. It also recommended a pilot study of seven nuclear facilities to assess the technical feasibility of the recommended study designs. The Phase 2 study is the assessment of cancer risks. The pilot, which is part of the Phase 2 study, is being carried out in two steps: pilot planning and pilot execution. The pilot planning (current step) aims to plan for the pilot study. The pilot execution (next step) aims to carry out the pilot study and evaluate the technical feasibility of implementing the two study designs recommended in the Phase 1 study. If implementation of the study designs is feasible, the methods developed and tested in the pilot study could be used to conduct a nationwide study. Analysis of Cancer Risks in Populations Near Nuclear Facilities: Phase 2 Pilot Planning provides advice to the National Academy of Sciences in performing a number of tasks related to the planning for a pilot epidemiological study, such as identifying the processes for selecting qualified individuals and/or organizations to perform epidemiological and dosimetric tasks and initiating effluent release and meteorological data collection in preparation for estimating doses to the people who live near the pilot nuclear facilities. This report brief report serves as a public record of the committee's advice to the National Academy of Sciences on general methodological considerations involved in carrying out the pilot study.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.